CollPlant Biotechnologies (FRA:CPT) Insider Ownership: 0.00 % (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CPT CollPlant Biotechnologies Ltd FRA:CPT
44 GF Score
Price €3.50
GF Value €2.34
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CollPlant Biotechnologies Insider Ownership?

CollPlant Biotechnologies FRA:CPT 44 Insider Ownership is 0.00 % as of Sep. 07, 2026. GuruFocus rates FRA:CPT with a GF Score™ of 44/100 and a GF Value™ of €2.34 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CollPlant Biotechnologies's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CollPlant Biotechnologies's Institutional Ownership is 0.05%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CollPlant Biotechnologies's Float Percentage Of Total Shares Outstanding is 79.54%.

CollPlant Biotechnologies Insider Ownership Historical Data

* Premium members only.

The historical data trend for CollPlant Biotechnologies's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CollPlant Biotechnologies Insider Ownership Chart

CollPlant Biotechnologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CollPlant Biotechnologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CPT
44GF Score
CollPlant Biotechnologies Ltd FRA:CPT
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CollPlant Biotechnologies Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
CollPlant Biotechnologies (FRA:CPT) has a Insider Ownership of 0.00 % as of Sep. 07, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on CollPlant Biotechnologies and its competitors.
Is CollPlant Biotechnologies' Insider Ownership too high?
CollPlant Biotechnologies' current Insider Ownership is 0.00 %. Overall, CollPlant Biotechnologies has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CollPlant Biotechnologies' Insider Ownership compare to DRMA and AAGH?
CollPlant Biotechnologies' Insider Ownership of 0.00 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on CollPlant Biotechnologies and its competitors. CollPlant Biotechnologies's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CollPlant Biotechnologies stock overvalued right now?
Based on GuruFocus' analysis, CollPlant Biotechnologies (FRA:CPT) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.34, compared to a current price of €3.50 — trading 49.6% above its estimated fair value. The current Insider Ownership is 0.00 %. CollPlant Biotechnologies' overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For CollPlant Biotechnologies (FRA:CPT), the current Insider Ownership is 0.00 % as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CollPlant Biotechnologies (FRA:CPT) Overvalued in 2026?

Based on GuruFocus' analysis, CollPlant Biotechnologies stock appears to be overvalued. The current stock price of €3.50 is trading 49.6% above its estimated GF Value™ of €2.34. GuruFocus considers CollPlant Biotechnologies to be Significantly Overvalued.

Key valuation signals for FRA:CPT:

  • Insider Ownership: 0.00 %
  • GF Value™: €2.34 vs. price of €3.50 (49.6% above fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the FRA:CPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CollPlant Biotechnologies Business Description

Other Exchanges CLGN:USA
Address 4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
44GF Score

Get the complete analysis for FRA:CPT

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.50
Price
€2.34
GF Value